MyFinsight
Home
Blog
About
Contact
Download
Download image
Proceeds from the
issuance of common stock,...
$93,558K
Issuance of common stock
from atm offering,...
$12,745K
Proceeds from the
issuance of common stock...
$291K
Proceeds from issuance of
common stock in...
$14K
Net cash provided by
financing activities
$100,347K
Effect of exchange rate
changes on cash and cash...
$19K
Canceled cashflow
$6,261K
Net decrease in cash
and cash...
-$80,980K
Canceled cashflow
$100,366K
Stock-based compensation
$20,939K
Non-cash finance lease
expense
$11,697K
Accrued and other
current liabilities
$7,432K
Non-cash operating lease
expense
$3,671K
Depreciation
$1,646K
Accounts payable
$1,550K
Accretion of operating
lease liabilities
$532K
Accrued interest
payable under finance...
$291K
Loss on foreign
currency exchange rates
$225K
Proceeds from maturities
of investments
$50,000K
Principal payments on
finance leases
$6,261K
Net cash used in
operating activities
-$131,080K
Canceled cashflow
$47,983K
Net cash (used in)
provided by investing...
-$50,266K
Canceled cashflow
$50,000K
Net loss
-$167,856K
Lease liabilities
-$4,227K
Other assets
$2,866K
Prepaid expenses and
other current assets
$2,559K
Amortization of discount on
investments
$1,555K
Purchases of investments
$99,037K
Purchases of property and
equipment
$1,229K
Back
Back
Cash Flow
source: myfinsight.com
Cabaletta Bio, Inc. (CABA)
Cabaletta Bio, Inc. (CABA)